Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of intravenous ETX2514 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection

Drugs mentioned

• ETX2514 (ETX2514)

Snippet

Sponsor: Entasis Therapeutics | Conditions: Acinetobacter Baumannii Infection | Phase 1 | Status: COMPLETED